(Q46894221)

26 December 2017

title

Depression and anxiety with rimonabant (English)

1 reference

26 December 2017

author

Philip B. Mitchell

series ordinal

1

1 reference

26 December 2017

author name string

Margaret J Morris

series ordinal

2

1 reference

26 December 2017

language of work or name

English

0 references

publication date

1 November 2007

1 reference

26 December 2017

published in

The Lancet

1 reference

26 December 2017

volume

370

1 reference

26 December 2017

issue

9600

1 reference

26 December 2017

page(s)

1671-1672

1 reference

26 December 2017

Endocannabinoid control of food intake and energy balance

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961705-X

7 January 2021

The obesity pipeline: current strategies in the development of anti-obesity drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961705-X

7 January 2021

Rimonabant for overweight or obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961705-X

7 January 2021

Drug treatments for obesity: orlistat, sibutramine, and rimonabant.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961705-X

7 January 2021

Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961705-X

7 January 2021

Is obesity associated with major depression? Results from the Third National Health and Nutrition Examination Survey

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961705-X

7 January 2021

Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961705-X

7 January 2021

Involvement of the endocannabinoid system in the ability of long-term tricyclic antidepressant treatment to suppress stress-induced activation of the hypothalamic-pituitary-adrenal axis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961705-X

7 January 2021

Effects of the cannabinoid CB1 receptor antagonist rimonabant in models of emotional reactivity in rodents

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961705-X

7 January 2021

Leptin: a potential novel antidepressant

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961705-X

7 January 2021

Role of the endocannabinoid system in depression and suicide

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961705-X

7 January 2021

10.1016/S0140-6736(07)61705-X

Identifiers

DOI

1 reference

26 December 2017

1 reference

26 December 2017